{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "A panel of scientific advisers recommended on Friday that the Food and Drug Administration approve a new type of drug to battle glaucoma. Studies have shown that the drug, Latanoprost, works better than standard therapy, but has the startling side effect of permanently turning some blue or green eyes brown. The panel said that the manufacturer, Pharmacia Upjohn Inc., should continue to study the drug's long-term safety and clearly label that it can cause the eye color change.", "headline": {"main": "Panel Backs a New Drug to Combat Glaucoma"}, "abstract": null, "print_page": "29", "word_count": 467, "_id": "4fd1d1bd8eb7c8105d70c753", "snippet": "A panel of scientific advisers recommended on Friday that the Food and Drug Administration approve a new type of drug to battle glaucoma. Studies have shown that the drug, Latanoprost, works better than standard therapy, but has the startling side...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1995/12/10/us/panel-backs-a-new-drug-to-combat-glaucoma.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "PHARMACIA & UPJOHN INC FOOD & DRUG ADMINISTRATION"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "LATANOPROST (DRUG)"}, {"name": "subject", "value": "GLAUCOMA"}, {"name": "subject", "value": "EYES AND EYESIGHT"}], "byline": {"organization": "AP", "original": "AP", "person": []}, "document_type": "article", "pub_date": "1995-12-10T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Out of the spotlight of the Medicare debate, the nation's private health plans have obtained a series of technical changes in the overhaul approved by Congress that stand to reap them billions of dollars. One adjustment would raise the rate by which Government reimbursements would increase next year by several percentage points more than would have been done in previous versions of the legislation, resulting in billions of dollars more for the health-care companies.", "headline": {"main": "HEALTH LOBBYISTS WIN ADJUSTMENTS TO MEDICARE PLAN"}, "abstract": null, "print_page": "1", "word_count": 2279, "_id": "4fd1ecea8eb7c8105d73ea16", "snippet": "Out of the spotlight of the Medicare debate, the nation's private health plans have obtained a series of technical changes in the overhaul approved by Congress that stand to reap them billions of dollars.         One adjustment would raise the rate...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1995/12/10/us/health-lobbyists-win-adjustments-to-medicare-plan.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CLINTON, BILL"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "MEDICARE"}, {"name": "subject", "value": "HEALTH MAINTENANCE ORGANIZATIONS"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "LOBBYING ANDLOBBYISTS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Martin", "lastname": "GOTTLIEB"}], "original": "By MARTIN GOTTLIEB"}, "document_type": "article", "pub_date": "1995-12-10T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 2, "offset": 0, "time": 57}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}